Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014

Date: August 30, 2014
Pages: 67
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A2FAD305185EN
Leaflet:

Download PDF Leaflet

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014' provides data on the Adult Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Adult Respiratory Distress Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Adult Respiratory Distress Syndrome
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Adult Respiratory Distress Syndrome
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Adult Respiratory Distress Syndrome Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pneuma Pharmaceuticals Incorporated
Clinical Trial Overview of Pneuma Pharmaceuticals Incorporated
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Discovery Laboratories, Inc.
Clinical Trial Overview of Discovery Laboratories, Inc.
Debiopharm International S.A.
Clinical Trial Overview of Debiopharm International S.A.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Clinical Trial Overview of Top Institutes / Government
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
Boston Medical Center
Clinical Trial Overview of Boston Medical Center
University of Turin
Clinical Trial Overview of University of Turin
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
University Hospital Freiburg
Clinical Trial Overview of University Hospital Freiburg
Sunnybrook Health Sciences Centre
Clinical Trial Overview of Sunnybrook Health Sciences Centre
University of Washington
Clinical Trial Overview of University of Washington
University of Michigan
Clinical Trial Overview of University of Michigan
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
University of Oklahoma
Clinical Trial Overview of University of Oklahoma
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014
Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Suspended Clinical Trials, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Terminated Clinical Trials, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Adult Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pneuma Pharmaceuticals Incorporated, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Discovery Laboratories, Inc., 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Debiopharm International S.A., 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turin, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2014

LIST OF FIGURES

Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014
Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Adult Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2014
Adult Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Adult Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Adult Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Ask Your Question

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: